Dysregulation of immune cell and cytokine signalling correlates with clinical outcomes in myelodysplastic syndrome (MDS).
Saved in:
| Title: | Dysregulation of immune cell and cytokine signalling correlates with clinical outcomes in myelodysplastic syndrome (MDS). |
|---|---|
| Authors: | Chee L; Australian Cancer Research Foundation (ACRF) Translational Laboratory, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.; The Australasian Leukaemia and Lymphoma Group, Richmond, Victoria, Australia., Ritchie D; Australian Cancer Research Foundation (ACRF) Translational Laboratory, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.; The Australasian Leukaemia and Lymphoma Group, Richmond, Victoria, Australia., Ludford-Menting M; Australian Cancer Research Foundation (ACRF) Translational Laboratory, The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Ripley J; Australian Cancer Research Foundation (ACRF) Translational Laboratory, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Liverpool Hospital, Liverpool, New South Wales, Australia., Chung J; Melbourne Bioinformatics, The University of Melbourne, Parkville, Victoria, Australia., Park D; Melbourne Bioinformatics, The University of Melbourne, Parkville, Victoria, Australia., Norton S; Nanix Limited, Dunedin, New Zealand., Kenealy M; The Australasian Leukaemia and Lymphoma Group, Richmond, Victoria, Australia.; Cabrini Hospital, Malvern, Victoria, Australia.; Monash University, Clayton, Victoria, Australia., Koldej R; Australian Cancer Research Foundation (ACRF) Translational Laboratory, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia. |
| Source: | European journal of haematology [Eur J Haematol] 2022 Apr; Vol. 108 (4), pp. 342-353. Date of Electronic Publication: 2022 Feb 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34963023 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dysregulation of immune cell and cytokine signalling correlates with clinical outcomes in myelodysplastic syndrome (MDS). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chee+L%22">Chee L</searchLink>; Australian Cancer Research Foundation (ACRF) Translational Laboratory, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.; The Australasian Leukaemia and Lymphoma Group, Richmond, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Ritchie+D%22">Ritchie D</searchLink>; Australian Cancer Research Foundation (ACRF) Translational Laboratory, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.; The Australasian Leukaemia and Lymphoma Group, Richmond, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Ludford-Menting+M%22">Ludford-Menting M</searchLink>; Australian Cancer Research Foundation (ACRF) Translational Laboratory, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Ripley+J%22">Ripley J</searchLink>; Australian Cancer Research Foundation (ACRF) Translational Laboratory, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Liverpool Hospital, Liverpool, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Chung+J%22">Chung J</searchLink>; Melbourne Bioinformatics, The University of Melbourne, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Park+D%22">Park D</searchLink>; Melbourne Bioinformatics, The University of Melbourne, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Norton+S%22">Norton S</searchLink>; Nanix Limited, Dunedin, New Zealand.<br /><searchLink fieldCode="AU" term="%22Kenealy+M%22">Kenealy M</searchLink>; The Australasian Leukaemia and Lymphoma Group, Richmond, Victoria, Australia.; Cabrini Hospital, Malvern, Victoria, Australia.; Monash University, Clayton, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Koldej+R%22">Koldej R</searchLink>; Australian Cancer Research Foundation (ACRF) Translational Laboratory, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228703985%22">European journal of haematology</searchLink> [Eur J Haematol] 2022 Apr; Vol. 108 (4), pp. 342-353. <i>Date of Electronic Publication: </i>2022 Feb 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell%22">Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8703985 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1600-0609 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209024441%22">09024441 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34963023 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/ejh.13742 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 342 Titles: – TitleFull: Dysregulation of immune cell and cytokine signalling correlates with clinical outcomes in myelodysplastic syndrome (MDS). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chee L – PersonEntity: Name: NameFull: Ritchie D – PersonEntity: Name: NameFull: Ludford-Menting M – PersonEntity: Name: NameFull: Ripley J – PersonEntity: Name: NameFull: Chung J – PersonEntity: Name: NameFull: Park D – PersonEntity: Name: NameFull: Norton S – PersonEntity: Name: NameFull: Kenealy M – PersonEntity: Name: NameFull: Koldej R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2022 Apr Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1600-0609 Numbering: – Type: volume Value: 108 – Type: issue Value: 4 Titles: – TitleFull: European journal of haematology Type: main |
| ResultId | 1 |